Search

Your search keyword '"Lena Hjelte"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Lena Hjelte" Remove constraint Author: "Lena Hjelte"
125 results on '"Lena Hjelte"'

Search Results

1. Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden

2. MAIT cell counts are associated with the risk of hospitalization in COPD

3. Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination

4. A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function

5. Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study

6. The Effects of Aspergillus fumigatus Colonization on Lung Function in Patients with Cystic Fibrosis

7. Psychometric evaluation of the Swedish translation of the revised Cystic Fibrosis Questionnaire in adults

8. Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis-population compared with recommendations

9. A 16-year retrospective study on fungal prevalence and diversity in patients with cystic fibrosis: Candida dubliniensis was associated with a decline in lung function

10. The Effects of Aspergillus fumigatus Colonization on Lung Function in Patients with Cystic Fibrosis

11. Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

13. Severely Impaired Control of Bacterial Infections in a Patient With Cystic Fibrosis Defective in Mucosal-Associated Invariant T Cells

14. P257 Assessing possible role of enterovirus infections in diabetes onset in a Swedish cohort of cystic fibrosis patients

15. P398 Most adult patients with cystic fibrosis at Stockholm Cystic Fibrosis Centre have a full-time or part-time occupation

17. WS19.5 Decrease of faecal calprotectin in adults after initiation of Orkambi®, a Registry-based study

18. Cystic fibrosis bronchial epithelial cells have impaired ability to activate vitamin D

19. Vitamin D treatment modulates immune activation in cystic fibrosis

20. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial

21. Time Point to Perform Lung Function Tests Evaluating the Effects of an Airway Clearance Therapy Session in Cystic Fibrosis

22. Associations between genetics, medical status, physical exercise and psychological well-being in adults with cystic fibrosis

23. Psychometric evaluation of the Swedish translation of the revised Cystic Fibrosis Questionnaire in adults

24. Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function

25. Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial

26. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations

27. Age at diagnosis and disease progression of cystic fibrosis in an area without newborn screening

28. Mental health and sense of coherence among Swedish adults with cystic fibrosis

29. Parental support for newborn screening for cystic fibrosis

30. Gender differences in the Scandinavian cystic fibrosis population

31. P068 Presence of Candida dubliniensis in the cystic fibrosis respiratory tract was associated with a significant decline in lung function – results from a 16-year retrospective study

32. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease

33. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients

34. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods

35. Expression of Intestinal and Lung Alkaline Sphingomyelinase and Neutral Ceramidase in Cystic Fibrosis F508del Transgenic Mice

36. Anxiety and depression in adults with cystic fibrosis: a comparison between patients and the general population in Sweden and three other European countries

37. Multicentre chest computed tomography standardisation in children and adolescents with cystic fibrosis: the way forward

38. Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells

39. Heparin can improve the viability of transfected cystic fibrosis cell lines in vitro

40. Measurement of halide efflux from cultured and primary airway epithelial cells using fluorescence indicators

41. 264 Natural history of patients with cystic fibrosis carrying nonsense mutations: an analysis of placebo-treated patients from the 009 study

42. WS13.1 Ataluren significantly reduces exacerbations in nonsense mutation cystic fibrosis patients not receiving tobramycin

43. Predictors of deterioration of lung function in cystic fibrosis*

44. Nasal Polyps in Cystic Fibrosis

46. 393 Anxiety and depression can predict the development in lung function in adults with cystic fibrosis

47. Non-invasive Ventilation as Airway Clearance Technique in Cystic Fibrosis

48. TNF-A and IL-8 in Consecutive Sputum Samples from Cystic Fibrosis Patients During Antibiotic Treatment

49. Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden

50. Polymorphic Expression of Multidrug Resistance mRNA in Lung Parenchyma of Nonpregnant and Pregnant Rats: A Comparison to Cystic Fibrosis mRNA Expression

Catalog

Books, media, physical & digital resources